WallStreetZenWallStreetZen

NASDAQ: SYRE
Spyre Therapeutics Inc Stock Ownership - Who owns Spyre Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Spyre Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jeffrey W. AlbersDirector2026-08-075,000$104.47
$522.35kSell
Jeffrey W. AlbersDirector2026-08-078,000$104.38
$835.04kSell
Jeffrey W. AlbersDirector2026-08-0710,000$104.68
$1.05MSell
Jeffrey W. AlbersDirector2026-08-075,000$10.39
$51.95kBuy
Scott L. BurrowsCFO2026-08-037,500$14.50
$108.75kBuy
Cameron TurtleCEO2026-08-031,392$96.82
$134.77kSell
Cameron TurtleCEO2026-08-035,635$95.93
$540.57kSell
Cameron TurtleCEO2026-08-037,157$95.10
$680.63kSell
Cameron TurtleCEO2026-08-03800$93.97
$75.18kSell
Scott L. BurrowsCFO2026-08-03100$97.10
$9.71kSell

1 of 8

SYRE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SYRE insiders and whales buy or sell their stock.

SYRE Shareholders

What type of owners hold Spyre Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC13.36%11,781,024$1.24BInstitution
Fairmount Funds Management LLC11.66%10,283,659$1.08BInsider
Blackrock Inc6.26%5,521,221$581.55MInstitution
Rtw Investments LP4.73%4,171,996$439.44MInstitution
Fairmount Funds Management LLC4.56%4,018,101$423.23MInstitution
Perceptive Advisors LLC4.29%3,783,225$398.49MInstitution
Venrock Adviser LLC4.18%3,685,448$388.19MInstitution
Baker Bros Advisors LP3.51%3,094,590$325.95MInsider
Vanguard Capital Management LLC3.47%3,057,401$322.04MInstitution
Orbimed Advisors LLC3.21%2,829,748$298.06MInsider

1 of 3

SYRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SYRE79.28%20.72%Net SellingNet Selling
KYMR78.37%21.63%Net SellingNet Selling
CRNX89.67%10.33%Net SellingNet Buying
IONS96.88%3.12%Net SellingNet Selling
PCVX88.92%11.08%Net SellingNet Selling
View Top Biotech Stocks

Spyre Therapeutics Stock Ownership FAQ

Who owns Spyre Therapeutics?

Spyre Therapeutics (NASDAQ: SYRE) is owned by 93.73% institutional shareholders, 24.50% Spyre Therapeutics insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Spyre Therapeutics shareholder, owning 10.28M shares representing 11.66% of the company. Fairmount Funds Management LLC's Spyre Therapeutics shares are currently valued at $1.06B.

If you're new to stock investing, here's how to buy Spyre Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.